Vanguard Personalized Indexing Management
EBS icon

Vanguard Personalized Indexing Management’s Emergent Biosolutions EBS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
16,554
-912
-5% -$7.63K ﹤0.01% 1996
2026
Q1 		$145K Sell
17,466
-789
-4% -$8.17K ﹤0.01% 1888
2025
Q4 		$226K Buy
18,255
+348
+2% +$3.73K ﹤0.01% 1675
2025
Q3 		$158K Buy
17,907
+83
+0.5% +$646 ﹤0.01% 1752
2025
Q2 		$114K Buy
17,824
+2,204
+14% +$12.6K ﹤0.01% 1716
2025
Q1 		$75.9K Buy
15,620
+896
+6% +$7.42K ﹤0.01% 1647
2024
Q4 		$141K Buy
14,724
+2,140
+17% +$19.6K ﹤0.01% 1573
2024
Q3 		$105K Sell
12,584
-1,117
-8% -$10.2K ﹤0.01% 1609
2024
Q2 		$93.4K Buy
+13,701
New +$59K ﹤0.01% 1536

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Vanguard Personalized Indexing Management's EBS Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Emergent Biosolutions (EBS) stake by 5.2% in Q2 2026, selling an estimated $7.63K and leaving 16,554 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Vanguard Personalized Indexing Management first reported a position in EBS in Q2 2024 and has held it in 9 quarters since. The position peaked at $226K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Vanguard Personalized Indexing Management held 16,554 shares of Emergent Biosolutions worth $139K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 912 Emergent Biosolutions shares in Q2 2026, an estimated $7.63K.
  • Emergent Biosolutions made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1996 holding.
  • Vanguard Personalized Indexing Management first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 9 quarters since.
  • Vanguard Personalized Indexing Management's Emergent Biosolutions position peaked at $226K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.